Sabine Allard

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

Annelies Michiels, Sandra Tuyaerts, Aude Bonehill et al. · Gene Therapy · 2005 · 91 citations

Life Sciences, Cell Biology, Immunology +14

35th Annual Meeting of the European Association for the Study of Diabetes

Arne Melander, Jonny Olsson, Gunnar Lindberg et al. · Diabetologia · 1999 · 86 citations

Medicine, Endocrinology, Internal Medicine +11

Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription

Pieter Pannus, Sofie Rutsaert, Stéphane De Wit et al. · Journal of the International AIDS Society · 2020 · 55 citations · Full text

Life Sciences, Molecular Biology, Hiv Control +10

iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Wesley de Jong, Joeri L. Aerts, Sabine Allard et al. · Trials · 2019 · 50 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17